Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Weed (BUDZ) EBITDA (2017 - 2025)

Weed has reported EBITDA over the past 12 years, most recently at -$750184.0 for Q4 2025.

  • Quarterly results put EBITDA at -$750184.0 for Q4 2025, down 470.56% from a year ago — trailing twelve months through Dec 2025 was -$1.4 million (down 168.87% YoY), and the annual figure for FY2025 was -$1.4 million, down 168.87%.
  • EBITDA for Q4 2025 was -$750184.0 at Weed, down from -$73949.0 in the prior quarter.
  • Over the last five years, EBITDA for BUDZ hit a ceiling of $735612.0 in Q3 2023 and a floor of -$1.2 million in Q2 2021.
  • Median EBITDA over the past 5 years was -$174237.0 (2021), compared with a mean of -$305790.9.
  • Biggest five-year swings in EBITDA: skyrocketed 338.58% in 2023 and later plummeted 470.56% in 2025.
  • Weed's EBITDA stood at -$174237.0 in 2021, then tumbled by 392.11% to -$857431.0 in 2022, then skyrocketed by 54.08% to -$393756.0 in 2023, then surged by 66.61% to -$131481.0 in 2024, then plummeted by 470.56% to -$750184.0 in 2025.
  • The last three reported values for EBITDA were -$750184.0 (Q4 2025), -$73949.0 (Q3 2025), and -$106504.0 (Q2 2025) per Business Quant data.